Who
Matthew J. Leonard
Director
Company insider
Files Form 4 as: Director, ANI Pharmaceuticals; Officer, Covetrus.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $841K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 8 Apr 2019
- Last trade
- 21 May 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Aug 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 25 Aug 2025filed 26 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $229K2,528 at $90.62 | filing |
| 18 Aug 2025filed 18 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $612K6,937 at $88.17 | filing |
| 22 May 2025filed 27 May 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,336 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,410 at $0.00 | filing |
| 21 Aug 2023filed 23 Aug 2023 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —7,583 at $0.00 | filing |
| 8 Apr 2019filed 10 Apr 2019 | Covetrusoption or derivative | SEC FORM 4 Code A | —91,860 at $0.00 | filing |
| 8 Apr 2019filed 10 Apr 2019 | Covetrusoption or derivative | SEC FORM 4 Code A | —136,972 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.